PRESS RELEASE published on 04/10/2025 at 18:15, 1 year 2 months ago EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma: Preliminary Q2 2025 figures exceed capital market expectations SCHOTT Pharma AG & Co. KGaA exceeds Q2 2025 expectations with EUR 252m revenues, EUR 72m EBITDA, and 28.6% EBITDA margin, maintaining full-year guidance. Detailed results on May 15, 2025 Revenues EBITDA SCHOTT Pharma Full-year Guidance Q2 2025
BRIEF published on 04/10/2025 at 16:03, 1 year 2 months ago SCHOTT Pharma Opens New Production Facility in Serbia European Market SCHOTT Pharma Pharmaceutical Manufacturing Serbia Facility Glass Ampoules
BRIEF published on 04/10/2025 at 16:03, 1 year 2 months ago SCHOTT Pharma ouvre une nouvelle usine de production en Serbie SCHOTT Pharma Marché Européen Installation En Serbie Ampoules En Verre Fabrication De Produits Pharmaceutiques
PRESS RELEASE published on 04/10/2025 at 15:58, 1 year 2 months ago Next expansion milestone achieved: SCHOTT Pharma opens production facility in Serbia to strengthen competitiveness in Europe SCHOTT Pharma opens new production facility in Serbia to strengthen competitiveness in Europe, creating 180 new jobs and increasing ampoule manufacturing capacity SCHOTT Pharma Competitiveness Serbia Production Facility Ampoule Manufacturing
BRIEF published on 02/13/2025 at 07:05, 1 year 4 months ago SCHOTT Pharma Begins Fiscal Year 2025 with Promising Results Revenue Growth EBITDA Margin Q1 Results High-value Solutions DCS Segment
BRIEF published on 02/13/2025 at 07:05, 1 year 4 months ago SCHOTT Pharma débute l'année fiscale 2025 avec des résultats prometteurs Marge EBITDA Croissance Des Revenus Résultats Du Premier Trimestre Des Solutions À Haute Valeur Ajoutée Segment DCS
PRESS RELEASE published on 02/13/2025 at 07:00, 1 year 4 months ago SCHOTT Pharma records good start into fiscal year and confirms full year outlook SCHOTT Pharma reports good start in Q1 2025 with EUR 230m revenues, confirms full year outlook. EBITDA margin at 25.1% as reported. High-value solutions share at 55% Revenues EBITDA Margin SCHOTT Pharma Full Year Outlook Q1 2025
BRIEF published on 02/04/2025 at 18:27, 1 year 5 months ago SCHOTT Pharma Holds Successful Annual General Meeting Annual General Meeting Shareholder Approval SCHOTT Pharma Profit Growth MDAX Promotion
BRIEF published on 02/04/2025 at 18:27, 1 year 5 months ago SCHOTT Pharma organise avec succès son assemblée générale annuelle SCHOTT Pharma Assemblée Générale Annuelle Approbation Des Actionnaires Croissance Des Bénéfices Promotion MDAX
PRESS RELEASE published on 02/04/2025 at 18:22, 1 year 5 months ago SCHOTT Pharma with successful Annual General Meeting: Shareholders approve all agenda items SCHOTT Pharma's successful Annual General Meeting for FY 2024 with all agenda items approved by shareholders, including new Supervisory Board member Dr. Wolfram Carius and KPMG as new auditor Annual General Meeting Shareholders SCHOTT Pharma KPMG Dr. Wolfram Carius
Published on 07/09/2026 at 00:00, 1 hour 4 minutes ago Alset AI Announces Closing of Shares for Debt Transaction
Published on 07/08/2026 at 15:25, 9 hours 39 minutes ago Rockhaven Announces Granting of Incentive Stock Options
Published on 07/08/2026 at 15:00, 10 hours 4 minutes ago Karbon-X Announces Strategic Partnership to Evaluate Kenya BioHub Initiative
Published on 07/08/2026 at 15:00, 10 hours 4 minutes ago GameSquare's Stream Hatchet Publishes Esports Live Streaming Trends Report
Published on 07/08/2026 at 23:08, 1 hour 56 minutes ago EQS-Adhoc: PSI Software SE: Publication of 2025 annual and consolidated financial statements postponed again by a few days
Published on 07/08/2026 at 21:00, 4 hours 4 minutes ago Legendary Entertainment and Warner Bros. Pictures Unveil Dune: Part Three Trailer and Behind-the-Scenes Images Showcasing Abu Dhabi as Arrakis
Published on 07/08/2026 at 19:42, 5 hours 22 minutes ago EQS-Adhoc: SMAG Mobile Antenna Masts AG sets final offer price for initial public offering (IPO) at EUR 46 per share
Published on 07/08/2026 at 18:52, 6 hours 11 minutes ago namR: PRONONCÉ DE LA LIQUIDATION JUDICIAIRE DE LA SOCIÉTÉ SA NAM.R
Published on 07/08/2026 at 20:00, 5 hours 4 minutes ago ALTAREA - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 07/08/2026 at 20:00, 5 hours 4 minutes ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 07/08/2026 at 20:00, 5 hours 4 minutes ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES JUIN 2026
Published on 07/08/2026 at 20:00, 5 hours 4 minutes ago ALTAREA - DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES JUIN 2026
Published on 07/08/2026 at 20:00, 5 hours 4 minutes ago ALTAREIT : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE